Performance evaluation of a large axial field-of-view PET scanner: SET-2400W

The SET-2400W is a newly designed whole-body PET scanner with a large axial field of view (20 cm). Its physical performance was investigated and evaluated. The scanner consists of four rings of 112 BGO detector units (22.8 mm in-plane × 50 mm axial × 30 mm depth). Each detector unit has a 6 (in-plane) × 8 (axial) matrix of BGO crystals coupled to two dual photomultiplier tubes. They are arranged in 32 rings giving 63 two-dimensional image planes. Sensitivity for a 20-cm cylindrical phantom was 6.1 kcps/kBq/m/ (224 kcps/μCi/ml) in the 2D clinical mode, and to 48.6 kcps/kBq/ ml (1.8 Mcps/μCi/ml) in the 3D mode after scatter correction. In-plane spatial resolution was 3.9 mm FWHM at the center of the field-of-view, and 4.4 mm FWHM tangentially, and 5.4 mm FWHM radially at 100 mm from the center. Average axial resolution was 4.5 mm FWHM at the center and 5.8 mm FWHM at a radial position 100 mm from the center. Average scatter fraction was 8% for the 2D mode and 40% for the 3D mode. The maximum count rate was 230 kcps in the 2D mode and 350 kcps in the 3D mode. Clinical images demonstrate the utility of an enlarged axial field-of-view scanner in brain study and whole-body PET imaging.     

Clinical evaluation of 2D versus 3D whole-body PET image quality using a dedicated BGO PET scanner

Purpose Three-dimensional positron emission tomography (3D PET) results in higher system sensitivity, with an associated increase in the detection of scatter and random coincidences. The objective of this work was to compare, from a clinical perspective, 3D and two-dimensional (2D) acquisitions in terms of whole-body (WB) PET image quality with a dedicated BGO PET system.Methods 2D and 3D WB emission acquisitions were carried out in 70 patients. Variable acquisition parameters in terms of time of emission acquisition per axial field of view (aFOV) and slice overlap between sequential aFOVs were used during the 3D acquisitions. 3D and 2D images were reconstructed using FORE+WLS and OSEM respectively. Scatter correction was performed by convolution subtraction and a model-based scatter correction in 2D and 3D respectively. All WB images were attenuation corrected using segmented transmission scans. Images were blindly assessed by three observers for the presence of artefacts, confidence in lesion detection and overall image quality using a scoring system.Results Statistically significant differences between 2D and 3D image quality were only obtained for 3D emission acquisitions of 3 min. No statistically significant differences were observed for image artefacts or lesion detectability scores. Image quality correlated significantly with patient weight for both modes of operation. Finally, no differences were seen in image artefact scores for the different axial slice overlaps considered, suggesting the use of five slice overlaps in 3D WB acquisitions.Conclusion 3D WB imaging using a dedicated BGO-based PET scanner offers similar image quality to that obtained in 2D considering similar overall times of acquisitions.     

Tumour detectability in 2-dimensional and 3-dimensional positron emission tomography using the SET-2400W: a phantom study

The purpose of this study was to investigate the detectability of small hot lesions in 2-dimensional transmission+emission (2D T/E), 2-dimensional simultaneous transmission+emission (2D simultaneous T/E) and 3-dimensional transmission+emission (3D T/E) acquisition modes in an 18F-fluorodeoxyglucose positron emission tomography (FDG PET) scan. The correlation between target detectability, target size, target to non-target uptake ratio (T/N ratio), and standardized uptake value (SUV) were studied. Small hot lesions ranging from 4.4 mm to 36.9 mm in diameter were set in a cylindrical phantom. The images of phantoms with T/N ratios of 2.0, 4.0, 6.0, 8.0, 9.6, 13.2, 17.5, 23.8 and 30.3 were obtained in 2D T/E, 2D simultaneous T/E and 3D T/E scans. Tumour uptake of 2-[18F]fluoro-2-deoxy-d-glucose (FDG) in a rabbit bearing VX-2 tumours was also studied in 2D T/E, 2D simultaneous T/E and 3D T/E scans. The target with a diameter > 10.6 mm and an actual T/N ratio from 6.0 to 30.3 could be identified on the images obtained with all the 2D T/E, 2D simultaneous T/E and 3D T/E acquisition modes. The detectability efficiency of a small hot target was found to be 77.8% in 2D T/E and 3D T/E, but 75.9% in 2D simultaneous T/E. The T/N ratio and recovery coefficient (RC) of the target from the 2D simultaneous T/E image was very similar to that from 2D T/E, and the SUV of the target from the 2D T/E image was almost the same as that from the 2D simultaneous T/E and 3D T/E images. This study indicated that 2D simultaneous T/E scanning and 3D T/E had similar abilities for detecting the tumour as did 2D T/E scanning. 2D T/E, 2D simultaneous T/E and 3D T/E scanning had the same feasibility for semi-quantitative analysis using SUV, as well as using the T/N ratios for 2D T/E and 2D simultaneous T/E. In contrast, the use of the T/N ratio in 3D T/E scanning gave an inferior result in semi-quantative analysis, although there might have been an improvement if a scatter correction had been performed.     

Performance of a whole-body PET scanner using curve-plate NaI(Tl) detectors.

A whole-body PET scanner, without interplane septa, has been designed to achieve high performance in clinical applications. The C-PET scanner, an advancement of the PENN PET scanners, is unique in the use of 6 curved NaI(Tl) detectors (2.54 cm thick). The scanner has a ring diameter of 90 cm, a patient port diameter of 56 cm, and an axial field of view of 25.6 cm. A (137)Cs point source is used for transmission scans. METHODS: Following the protocols of the International Electrotechnical Commission ([IEC] 61675-1) and the National Electrical Manufacturers Association ([NEMA] NU-2-1994 and an updated version, NU2-2001), point and line sources, as well as uniform cylinders, were used to determine the performance characteristics of the C-PET scanner. An image-quality phantom and patient data were used to evaluate image quality under clinical scanning conditions. Data were rebinned with Fourier rebinning into 2-dimensional (slice-oriented) datasets and reconstructed with an iterative reconstruction algorithm. RESULTS: The spatial resolution for a point source in the transaxial direction was 4.6 mm (full width at half maximum) at the center, and the axial resolution was 5.7 mm. For the NU2-1994 analysis, the sensitivity was 12.7 cps/Bq/mL (444 kcps/microCi/mL), the scatter fraction was 25%, and the peak noise equivalent count rate (NEC) for a uniform cylinder (diameter = 20 cm, length = 19 cm) was 49 kcps at an activity concentration of 11.2 kBq/mL. For the IEC protocol, the peak NEC was 41 kcps at 12.3 kBq/mL, and for the NU2-2001 protocol, the peak NEC was 14 kcps at 3.8 kBq/mL. The NU2-2001 NEC value differed significantly because of differences in the data analysis and the use of a 70-cm-long phantom. CONCLUSION: Compared with previous PENN PET scanners, the C-PET, with its curved detectors and improvements in pulse shaping, integration dead time, and triggering, has an improved count-rate capability and spatial resolution. With the refinements in the singles transmission technique and iterative reconstruction, image quality is improved and scan time is shortened. With single-event transmission scans interleaved between sequential emission scans, a whole-body study can be completed in <1 h. Overall, C-PET is a cost-effective PET scanner that performs well in a broad variety of clinical applications.     

Micro insert: a prototype full-ring PET device for improving the image resolution of a small-animal PET scanner

A full-ring PET insert device should be able to enhance the image resolution of existing small-animal PET scanners. METHODS: The device consists of 18 high-resolution PET detectors in a cylindric enclosure. Each detector contains a cerium-doped lutetium oxyorthosilicate array (12 x 12 crystals, 0.72 x 1.51 x 3.75 mm each) coupled to a position-sensitive photomultiplier tube via an optical fiber bundle made of 8 x 16 square multiclad fibers. Signals from the insert detectors are connected to the scanner through the electronics of the disabled first ring of detectors, which permits coincidence detection between the 2 systems. Energy resolution of a detector was measured using a (68)Ge point source, and a calibrated (68)Ge point source stepped across the axial field of view (FOV) provided the sensitivity profile of the system. A (22)Na point source imaged at different offsets from the center characterized the in-plane resolution of the insert system. Imaging was then performed with a Derenzo phantom filled with 19.5 MBq of (18)F-fluoride and imaged for 2 h; a 24.3-g mouse injected with 129.5 MBq of (18)F-fluoride and imaged in 5 bed positions at 3.5 h after injection; and a 22.8-g mouse injected with 14.3 MBq of (18)F-FDG and imaged for 2 h with electrocardiogram gating. RESULTS: The energy resolution of a typical detector module at 511 keV is 19.0% +/- 3.1%. The peak sensitivity of the system is approximately 2.67%. The image resolution of the system ranges from 1.0- to 1.8-mm full width at half maximum near the center of the FOV, depending on the type of coincidence events used for image reconstruction. Derenzo phantom and mouse bone images showed significant improvement in transaxial image resolution using the insert device. Mouse heart images demonstrated the gated imaging capability of the device. CONCLUSION: We have built a prototype full-ring insert device for a small-animal PET scanner to provide higher-resolution PET images within a reduced imaging FOV. Development of additional correction techniques are needed to achieve quantitative imaging with such an insert.     

Accuracy of 3D acquisition mode for myocardial FDG PET studies using a BGO-based scanner

Purpose The aim of the present study was to evaluate the quantitative and qualitative accuracy of 3D PET acquisitions for myocardial FDG studies. Methods Phantom studies were performed with both a homogeneous and an inhomogeneous phantom. Activity profiles were generated along the phantoms using 2D and several 3D reconstructions, varying the 3D scaling value to adjust the scatter correction algorithm. Furthermore, ten patients underwent a dynamic myocardial FDG PET scan, using an interleaved protocol consisting of frames with alternating 2D and 3D acquisition. For each myocardial study, 13 volumes of interest were defined, representing 13 myocardial segments. First, the optimal scaling value for the scatter correction algorithm was determined using data from the phantom and four patient studies. This scaling value was then applied to all ten patients. 2D and 3D acquisitions were compared for both static (i.e. activity concentrations in the last 2D and 3D frames) and dynamic imaging (calculation of the metabolic rate of glucose). Results For both phantom and patient studies, suboptimal results were obtained when the default scaling value for the scatter correction algorithm was used. After adjusting the scaling value, for all ten myocardial FDG studies, a very good correlation (r ² = 0.99) was obtained between 2D and 3D data. With the present protocol no significant differences were observed in qualitative interpretation. Conclusion The 3D FDG acquisition mode is accurate and has clear advantages over the 2D mode for myocardial FDG studies. A prerequisite is, however, optimisation of the 3D scatter correction algorithm.     

Investigation of count rate and deadtime characteristics of a high resolution PET system

Count rate and deadtime characteristics were investigated for a whole body positron emission tomography system by measuring prompt, delayed, and multiple (three or more detectors) coincidence rates and single detector rates as a function of input count rate by imaging a variety of short-lived positron emitting sources as a function of time. Data were collected with cylinder, ring, and point sources for a range of energy thresholds and fields of view. The largest source of deadtime loss involved processes that led to multiple coincidences, which are primarily true or accidental events in coincidence with an unrelated event. In measuring the count rate as a function of time for each type of event, components, with decay constants of 1, 2, or 3 times that of the isotope being measured, could be resolved corresponding to 1 (true events), 2 (accidental and some multiple events), or 3 (multiple events) independent nuclear disintegrations, respectively. Analysis of true, accidental, and multiple coincidence and singles count rate data allowed identification and evaluation of the magnitude of the sources of deadtime losses and provided a basis for a deadtime correction from data available from the PET system.     

Investigation of spatial resolution improvement by use of a mouth-insert detector in the helmet PET scanner

The dominant factor limiting the intrinsic spatial resolution of a positron emission tomography (PET) system is the size of the crystal elements in the detector. To increase sensitivity and achieve high spatial resolution, it is essential to use advanced depth-of-interaction (DOI) detectors and arrange them close to the subject. The DOI detectors help maintain high spatial resolution by mitigating the parallax error caused by the thickness of the scintillator near the peripheral regions of the field-of-view. As an optimal geometry for a brain PET scanner, with high sensitivity and spatial resolution, we proposed and developed the helmet–chin PET scanner using 54 four-layered DOI detectors consisting of a 16 × 16 × 4 array of GSOZ scintillator crystals with dimensions of 2.8 × 2.8 × 7.5 mm³. All the detectors used in the helmet–chin PET scanner had the same spatial resolution. In this study, we conducted a feasibility study of a new add-on detector arrangement for the helmet PET scanner by replacing the chin detector with a segmented crystal cube, having high spatial resolution in all directions, which can be placed inside the mouth. The crystal cube (which we have named the mouth-insert detector) has an array of 20 × 20 × 20 LYSO crystal segments with dimensions of 1 × 1 × 1 mm³. Thus, the scanner is formed by the combination of the helmet and mouth-insert detectors, and is referred to as the helmet–mouth-insert PET scanner. The results show that the helmet–mouth-insert PET scanner has comparable sensitivity and improved spatial resolution near the center of the hemisphere, compared to the helmet–chin PET scanner.     

Evaluation of the clinical performances of a large NaI(Tl) crystal 3D PET scanner.

AIM: This study was aimed at assessing the clinical performances of a NaI(Tl) crystal 3D PET scanner, C-PET (ADAC-UGM), using a multi-ring 2D BGO PET scanner (multi-ring PET), as a reference. METHODS: Thirty-seven oncological patients were studied in sequence with multi-ring PET and C-PET, within 30 days of a CT study. In order to assess the behaviour of C-PET in relation to acquisition count rate, patients were divided into 3 groups according to the count rate at the time of the C-PET scan acquisition. Group A (n=21): 3000-5000 kcounts/sec (recommended count rate range); Group B (n=8): <3000 Kcounts/sec and Group C (n=8): >5000 Kcounts/sec. RESULTS: The number of lesions detected by multi-ring PET and C-PET, classified according to size, was compared. For Group A and Group B there was a good agreement between C-PET and multi-ring PET in terms of lesion detectability (relative sensitivity: 99.9% and 96.0%, respectively), while for Group C the relative sensitivity of C-PET was 61.9%. CONCLUSION: Optimal performances of the C-PET scanner can thus be obtained at a count rate within or below the recommended range. Despite a lower lesion/background contrast resulting from a high scatter and random noise, the sensitivity of C-PET in detecting hypermetabolic lesions is comparable to that of multi-ring PET. These findings are discussed in relation to the physical performance of the two scanners and particularly in relation to the 3D vs 2D acquisition modality.     

Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes.

This study evaluates the 2-dimensional (2D) and 3-dimensional (3D) performance characteristics of a newly developed PET/CT scanner using the National Electrical Manufacturers Association (NEMA) NU 2-1994 (NU94) and NEMA NU 2-2001 (NU01) standards. The PET detector array consists of 10,080 individual bismuth germanate crystals arranged in 24 rings of 420 crystals each. The size of each crystal is 6.3 x 6.3 x 30 mm in the axial, transaxial, and radial dimensions, respectively. The PET detector ring diameter is 88.6 cm with axial and transaxial fields of view (FOVs) of 15.7 and 70 cm, respectively. The scanner has a uniform patient port of 70 cm throughout the PET and CT FOV, and the PET scanner is equipped with retractable septa to allow 2D and 3D imaging. METHODS: Spatial resolution, scatter fraction, sensitivity, counting rate, image quality, and accuracy as defined by the NEMA protocols of NU94 and NU01 for 2D and 3D modes are evaluated. The 2D mode data were acquired with a maximum ring difference of 5, whereas the 3D mode acquisition used ring differences of 23. Both 2D and 3D mode data were acquired with an energy window of 375-650 keV. Random estimation from singles counting rate was applied to all relevant analysis. In addition, images from 2 clinical whole-body oncology studies acquired in 2D and 3D modes are shown to demonstrate the image quality obtained from this scanner. RESULTS: The 2D NU94 transaxial resolution is 6.1-mm full width at half maximum (FWHM) 1 cm off center and increases to 6.9 mm tangential and 8.1 mm radial at a radius (R) of 20 cm. NU01 2D average transaxial (axial) FWHM resolution measured 6.1 (5.2) mm at R = 1 cm and 6.7 (6.1) mm at R = 10 cm. The NU94 scatter fraction for 2D (3D) was 13% (29%), whereas the NU01 scatter fraction gave 19% (45%). NU01 peak 2D (3D) noise equivalent counting rate (T(2)/[T + R + S]) was 90.2 (67.8) kilocount per second (kcps) at 52.5 (12) kBq/mL. Total 2D (3D) system sensitivity for true events is 8 (32.9) kcps/kBq/mL for NU94 and 1.95 (9.2) kcps/Bq for NU01. CONCLUSION: The results show excellent system sensitivity with relatively uniform resolution throughout the FOV, making this scanner highly suitable for whole-body studies.     

Correction methods for random coincidences in fully 3D whole-body PET: impact on data and image quality.

With the advantages of the increased sensitivity of fully 3-dimensional (3D) PET for whole-body imaging come the challenges of more complicated quantitative corrections and, in particular, an increase in the number of random coincidences. The most common method of correcting for random coincidences is the real-time subtraction of a delayed coincidence channel, which does not add bias but increases noise. An alternative approach is the postacquisition subtraction of a low-noise random coincidence estimate, which can be obtained either from a smoothed delayed coincidence sinogram or from a calibration scan or directly estimated. Each method makes different trade-offs between noise amplification, bias, and data-processing requirements. These trade-offs are dependent on activity injected, the local imaging environment (e.g., near the bladder), and the reconstruction algorithm. METHODS: Using fully 3D whole-body simulations and phantom studies, we investigate how the gains in noise equivalent count (NEC) rates from using a noiseless random coincidence estimation method are translated to improvements in image signal-to-noise ratio (SNR). The image SNR, however, depends on the image reconstruction method and the local imaging environment. RESULTS: We show that for fully 3D whole-body imaging using a particular set of scanners and clinical protocols, a low-noise estimate of random coincidences improves sinogram and image SNRs by approximately 15% compared with online subtraction of delayed coincidences. CONCLUSION: A 15% improvement in image SNR arises from a 32% increase in the NEC rate. Thus, scan duration can be reduced by 25% while still maintaining a constant total acquired NEC.     

Sensitivity and daily quality control of a mobile PET/CT scanner operating in 3-dimensional mode

This study investigated the stability of the sensitivity of a mobile PET/CT scanner and tested a phantom experiment to improve on the daily quality control recommendations of the manufacturer. Unlike in-house scanners, mobile PET/CT devices are subjected to a harsher, continuously changing environment that can alter their performance. The parameter of sensitivity was investigated because it reflects directly on standardized uptake value, a key factor in cancer evaluation. METHODS: A (68)Ge phantom of known activity concentration was scanned 6 times a month for 11 consecutive months using a mobile PET/CT scanner that operates in 3-dimensional mode only. The scans were acquired as 2 contiguous bed positions, with raw data obtained and reconstructed using parameters identical to those used for oncology patients, including CT-extracted attenuation coefficients and decay, scatter, geometry, and randoms corrections. After visual inspection of all reconstructed images, identical regions of interest were drawn on each image to obtain the activity concentration of individual slices. The original activity concentration was then decay-corrected to the scanning day, and the percentage sensitivity of the slice was calculated and graphed. The daily average sensitivity of the scanner, over 11 consecutive months, was also obtained and used to evaluate the stability of sensitivity. RESULTS: Our particular scanner showed a daily average sensitivity ranging from -8.6% to 6.5% except for one instance, when the sensitivity dropped by an unacceptable degree, 34.8%. CONCLUSION: Our 11-mo follow-up of a mobile PET/CT scanner demonstrated that its sensitivity remained within acceptable clinical limits except for one instance, when the scanner had to be serviced before patients could be imaged. To enhance our confidence in the uniformity of sensitivity across slices, we added a phantom scan to the daily quality control recommendations of the manufacturer.     

Optimization of injected dose based on noise equivalent count rates for 2- and 3-dimensional whole-body PET.

The noise equivalent count (NEC) rate index is used to derive guidelines on the optimal injected dose to the patient for 2-dimensional (2D) and 3-dimensional (3D) whole-body PET acquisitions. METHODS: We performed 2D and 3D whole-body acquisitions of an anthropomorphic phantom modeling the conditions for (18)F-FDG PET of the torso and measured the NEC rates for different activity levels for several organs of interest. The correlations between count rates measured from the phantom and those from a series of whole-body patient scans were then analyzed. This analysis allowed validation of our approach and estimation of the injected dose that maximizes NEC rate as a function of patient morphology for both acquisition modes. RESULTS: Variations of the phantom and patient prompt and random coincidence rates as a function of single-photon rates correlated well. On the basis of these correlations, we demonstrated that the patient NEC rate can be predicted for a given single-photon rate. Finally, we determined that patient single-photon rates correlated with the mean dose per weight at acquisition start when normalized by the body mass index. This correlation allows modifying the injected dose as a function of patient body mass index to reach the peak NEC rate in 3D mode. Conversely, we found that the peak NEC rates were never reached in 2D mode within an acceptable range of injected dose. CONCLUSION: The injected dose was adapted to patient morphology for 2D and 3D whole-body acquisitions using the NEC rate as a figure of merit of the statistical quality of the sinogram data. This study is a first step toward a more comprehensive comparison of the image quality obtained using both acquisition modes.     

Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems

Purpose This study evaluated the absolute quantification of iodine-124 (¹²⁴I) activity concentration with respect to the use of this isotope for dosimetry before therapies with ¹³¹I or ¹³¹I-labeled radiotherapeuticals. The recovery coefficients of positron emission tomography(/computed tomography) PET(/CT) systems using ¹²⁴I were determined using phantoms and then validated under typical conditions observed in differentiated thyroid cancer (DTC) patients. Methods Transversal spatial resolution and recovery measurements with ¹²⁴I and with fluorine-18 (¹⁸F) as the reference were performed using isotope-containing line sources embedded in water and six isotope-containing spheres 9.7 to 37.0 mm in diameter placed in water-containing body and cylinder phantoms. The cylinder phantom spheres were filled with ¹⁸F only. Measurements in two-dimensional (2D) and three-dimensional (3D) modes were performed using both stand-alone PET (EXACT HR⁺) and combined PET/CT (BIOGRAPH EMOTION DUO) systems. Recovery comparison measurements were additionally performed on a GE ADVANCE PET system using the cylinder phantom. The recovery coefficients were directly determined using the activity concentration of circular regions of interest divided by the prepared activity concentration determined by the dose calibrator. The recovery correction method was validated using three consecutive scans of the body phantom under our ¹²⁴I PET(/CT) protocol for DTC patients. Results Compared with that of ¹⁸F, transversal spatial resolution of ¹²⁴I was slightly, but statistically significantly degraded (7.4 mm vs. 8.3 mm, P<0.002). Using the body phantom, recovery was lower for ¹²⁴I than for ¹⁸F in both 2D and 3D modes. The ¹²⁴I recovery coefficient of the largest sphere was significantly higher in 2D than in 3D mode (81% vs. 75%, P=0.03). Remarkably, the ¹⁸F recovery coefficient for the largest sphere significantly deviated from unity (range of 87%–93%, P<0.004) for all scanners but the GE ADVANCE. The maximum range of inaccuracy of the measured ¹²⁴I activity concentration under in vivo conditions after applying partial volume correction was ±10% for spheres ≥12.6 mm in diameter. Conclusions Recovery correction is mandatory for ¹²⁴I PET quantification, even for large structures. To ensure accurate dosimetry, thorough absolute recovery measurements must be individually established for the particular PET scanner and radionuclide to be used.     

Performance characteristics obtained for a new 3-dimensional lutetium oxyorthosilicate-based whole-body PET/CT scanner with the National Electrical Manufacturers Association NU 2-2001 standard.

This article reports the results of performance measurements obtained for the lutetium oxyorthosilicate (LSO)-based whole-body PET/CT scanner Biograph 16 HI-REZ with the National Electrical Manufacturers Association (NEMA) NU 2-2001 standard. The Biograph 16 HI-REZ combines a multislice (16-slice) spiral CT scanner with a PET scanner composed of 24.336 LSO crystals arranged in 39 rings. The crystal dimensions are 4.0x4.0x20 mm3, and the crystals are organized in 13x13 blocks coupled to 4 photomultiplier tubes each. The 39 rings allow the acquisition of 81 images 2.0 mm thick, covering an axial field of view of 162 mm. The low- and high-energy thresholds are set to 425 and 650 keV, respectively, acquiring data within a 4.5-ns-wide coincidence window. METHODS: Performance measurements for the LSO-based PET/CT scanner were obtained with the NEMA NU 2-2001 standard, taking into account issues deriving from the presence of intrinsic radiation. RESULTS: The results obtained with the NEMA NU 2-2001 standard measurements were as follows: average transverse and axial spatial resolutions (full width at half maximum) at 1 cm and at 10 cm off axis of 4.61 (5.10) mm and 5.34 (5.91) mm, respectively; average sensitivity of 4.92 counts per second per kilobecquerel for the 2 radial positions (0 and 10 cm); 34.1% system scatter fraction; and peak noise equivalent count (NEC) rates of 84.77 kilocounts per second (kcps) at 28.73 kBq/mL (k=1 in the NEC formula; noiseless random correction) and 58.71 kcps at 21.62 kBq/mL (k=2; noisy random correction). CONCLUSION: The new integrated PET/CT system Biograph 16 HI-REZ has good overall performance, with, in particular, a high resolution, a low scatter fraction, and a very good NEC response.     

The influence of resolution recovery by using collimator detector response during 3D OSEM image reconstruction on (99m)Tc-ECD brain SPET images

Partial volume effect, due to the poor spatial resolution of single photon emission tomography (SPET), significantly restricts the absolute quantification of the regional brain uptake and limits the accuracy of the absolute measurement of blood flow. In this study the importance of compensation for the collimator-detector response (CDR) in the technetium-99m ethyl cysteinate dimer ((99m)Tc-ECD) brain SPET was assessed, by incorporating system response in the ordered-subsets expectation maximization (OSEM) reconstruction algorithm. By placing a point source of (99m)Tc at different distances from the face of the collimator, CDR were found and modeled using Gaussian functions. A fillable slice of the brain phantom was designed and filled by (99m)Tc. Projections acquired from the phantom and also 4 patients who underwent the (99m)Tc-ECD brain SPET were used in this study. To reconstruct the images, 3D OSEM algorithm was used. System blurring functions were modeled, during the reconstruction in both projection and backprojection steps. Our results were compared with the conventional resolution recovery using Metz filter in filtered backprojection (FBP). Visual inspection of the images was performed by six nuclear medicine specialists. Quantitative analysis was also studied by calculating the contrast and the count density of the reconstructed images. For the phantom images, background counts and noise were decreased by 3D OSEM compared to the FBP-Metz method. Quantitatively, the ratio of the counts of the occupied hot region to that of the cold region of the reconstructed by FBP-Metz images was 1.14. This value was decreased from 1.12 to 0.86 for 3D OSEM of 2 and 30 iterations respectively. The reference value was 0.85 for the planar image. For clinical images, hot to cold regions (grey to white matter), the count ratio was increased from 1.44 in FBP-Metz to 3.2 and 4 in 3D OSEM with 10 and 20 iterations respectively. Based on the interpretability of images, the best scores (3.79±0.51) by the physicians were given to the images reconstructed by 3D OSEM and 10 iterations. This value was 0.63±0.77 for FBP-Metz images. In conclusion, by incorporating the distance dependent CDR during 3D OSEM, it was possible to reconstruct the brain images with much higher resolution and contrast as compared to the conventional resolution recovery method, which used FBP-Metz. It was however important to make a trade-off between noise and resolution by determining an optimum iterations number.     

Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PET.

Whole-body radiation dosimetry of 11C-raclopride was performed in healthy human volunteers. METHODS: Subjects (n = 6) were scanned with PET. Subjects received single-bolus injections of 11C-raclopride (S-(-)-3,5-dichloro-N-[(1-ethyl-2-pyrrolidinyl)]methyl-2-hydroxy-6-methoxybenzamide) (533 +/- 104 MBq) and were scanned for approximately 110 min with a 2-dimensional whole-body protocol. Regions of interest were placed over all visually identifiable organs and time-activity curves were generated. Residence times were computed as the area under the curve of the time-activity curves, normalized to injected activities and standard values of organ volumes. Absorbed doses were computed according to the MIRD schema with MIRDOSE3.1 software. RESULTS: Organs with the highest radiation burden were gallbladder wall, small intestine, liver, and urinary bladder wall. CONCLUSION: On the basis of the estimated absorbed dose, the maximum allowable single study dose under U.S. federal regulations for studies performed under Radiation Drug Research Committee is 1.58 GBq (42.8 mCi). This is still considerably higher than the doses of 11C-raclopride commonly used in research PET (370-555 MBq).     

胆囊及胆总管结石MRC:3D原始图与MIP图对比研究

目的 :评价磁共振胆管成像 (MRC)三维原始图 (简称为原始图 )与 3D最大强度投影 (MIP)重建图像 (简称为MIP图 )在胆囊结石及胆总管结石中的应用价值。方法 :对 42例明确诊断为胆囊或胆总管结石的患者行 3DFSE扫描 ,获得原始图后 ,经工作站行靶最大强度投影 (MIP)重建得到三维立体图。两位有经验的放射学医师对图像进行分析 ,在病变的显示与否上取得一致。然后 ,对原始图及MIP图对结石的显示率进行统计学处理。结果 :在胆总管结石的显示上 ,原始图及MIP的显示率分别为 93 .3 3 %和 86.67% ,两者差异无显著性意义 (P >0 .0 5 ) ;而对于胆囊结石 ,显示率分别为97.0 6%和 2 3 .5 3 % ,两者间差异存在显著性意义 (P <0 .0 5 )。结论 :原始图及MIP图在显示胆总管结石上 ,两者具有同样较高的临床价值 ,而在显示胆囊结石上 ,原始图的临床应用价值要明显高于MIP图